Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on May 2, 2019, to report its first-quarter financial results for the period ended March 31, 2019. The press release, included as an exhibit, details both GAAP and non-GAAP financial performance. Management emphasizes the usefulness of non-GAAP measures for investors, as these metrics are utilized internally for operational, budgeting, and financial planning. Investors are encouraged to review these non-GAAP figures alongside the company's official GAAP financial statements and the provided reconciliation tables for a comprehensive understanding.
Key Highlights
- 1Gilead Sciences announced its Q1 2019 financial results via an 8-K filing on May 2, 2019.
- 2The filing includes a press release detailing financial performance for the quarter ended March 31, 2019.
- 3Both GAAP and non-GAAP financial information are presented in the press release.
- 4Management believes non-GAAP financial measures provide valuable insights for investors.
- 5Non-GAAP measures are used internally by Gilead for operating, budgeting, and financial planning.
- 6Investors should consider non-GAAP information in conjunction with GAAP financial statements.
- 7Reconciliation between GAAP and non-GAAP financial information is available in the press release.